Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN140,06140,10,21
Msft-1,34
Nokia10,8211,1153,27
IBM-0,67
Mercedes-Benz Group AG50,1350,06-0,38
PFE-3,02
09.05.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 08.05.2026
ISHARES U.S. MEDICAL DEVICES (NY Consolidated)
Závěr k 8.5.2026 Změna (%) Změna (USD) Objem obchodů (USD)
49,01 -1,98 -0,99 82 492 209
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 10.05.2026
Popis společnosti
Obecné informace
Název společnostiiShares Dow Jones US Medical Dev.(ETF)
TickerIHI
Kmenové akcie:Equity ETFs
RICIHI
ISIN-
Poslední známé roční výsledky30.04.2015
Poslední známé čtvrtletní výsledky30.04.2015
Akcie v oběhu k 18.08.2020 26 600 000
MěnaUSD
Kontaktní informace
UliceC/o SEI Investments
MěstoOaks
PSČ19456
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 

Business Summary: iShares U.S. Medical Devices ETF (the Fund), formerly iShares Dow Jones U.S. Medical Devices Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Medical Equipment Index (the Index). The Index measures the performance of the medical equipment sector of the United States equity market, and includes medical equipment companies, such as manufacturers and distributors of medical devices, such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, x-ray machines, and other non-disposable medical devices. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund’s investment advisor is BlackRock Fund Advisors.
Financial Summary: BRIEF: For the fiscal year ended 30 April 2015, iShares Dow Jones US Medical Dev.(ETF) revenues increased 64% to $8.4M. Net income increased 67% to $157.9M. Revenues reflect Dividends from Unaffiliated Issuers increase of 69% to $8.2M, Interest from Affiliated Issuers remaining flat at $0K. Net income benefited from Unrealized Appreciation/Depreciation increase from $43.6M to $124.7M (income).
Odvětvová klasifikace
TRBC2012Investment Trusts
RBSS2004Investment Trusts
MGINDUSTRYMisc. Financial Services
MGSECTORFinancial
NAICSOpen-End Investment Funds
SICManagement Investment, Open-End



  • Poslední aktualizace: 10.05.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the Board of TrusteesGeorge Parker8101.01.2010
President, TrusteeMichael Latham5401.01.2007
Chief Financial Officer, TreasurerJack Gee5701.01.2008
Chief Operating Officer, Executive Vice PresidentGeoffrey Flynn-01.01.2008
Executive Vice PresidentAmy Schioldager5801.01.2007
Vice President, Chief Legal OfficerIra Shapiro5201.01.2007
Vice PresidentMatt Tucker-01.01.2007
SecretaryEilleen Clavere6101.01.2007